Investor Relations Captor Therapeutics ®
Candidate for member of the Supervisory Board of the Company
Publication date:
Publication time:
Current report no. 60/2023
Date of drafting: 12.12.2023
Subject: Candidate for member of the Supervisory Board of the Company
Legal basis: Article 56(1)(2) of the Act on Offering - current information.
The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the "Company"), hereby announces that in connection with the Extraordinary General Meeting of the Company scheduled for January 4, 2024, it has received a draft resolution from the Company's shareholder, Mr. Michal Walczak, regarding the appointment of Mr. Charles Kunsch (Charles Kunsch) to the Company's Supervisory Board.
The Company, in the attachment to this report, discloses the draft resolution and a CV of the above-mentioned candidate.
Detailed legal basis: § 19(1)(4) of the Regulation of the Minister of Finance of 29 March 2018 on current and periodic information provided by issuers of securities and conditions for recognising as equivalent information required by the laws of a non-member state.